Epstein Secrets

esented the case to the U.S. Attomey’s Office for the Southern District of Florida. In 2007, the Office contacted counsel

district court decisions, which provides further support for the conclusion that the CVRA applies before charges have been filed. In United States v. Rubin,” victims of a federal securities fraud argued that they had CVRA rights even before prosecutors filed a superseding indictment covering the specific

rights even before prosecutors filed a superseding indictment covering the specific crimes affecting the victims. Citing Dean, the District Court for the Eastern District of New York agreed that the rights were expansive and could apply before charges were filed but were subject to the outer limit that the Government has at least

sented the case to the U.S. Attorney's Office for the Southern District of Florida. In 2007, the Office contacted counsel

isions, which provides further 79 victims of a support for the conclusion that the CVRA applies before charges have been filed. In United States v. Rubin, federal securities fraud argued that they had CVRA rights even before prosecutors filed a superseding indictment covering the specific crimes affec

ights even before prosecutors filed a superseding indictment covering the specific crimes affecting the victims. Citing Dean, the District Court for the Eastern District of New York agreed that the rights ® John W. Gillis & Douglas E. Beloof, The Next Step for a Maturing Victim Rights Movement: Enforcing Crime Victim Rights in t

respect for [his or her] dignity and privacy,’ ... may apply before any prosecution is underway" (quoting /8 U.S.C. § 377I(a))); cf. United States v. Rubin, 558 F. Supp. 2d 411, 419 (E.D.N.Y. 2008) (assuming without deciding that some federal victim rights may apply before any prosecution is under way, b

onvincing Congress to expand their discretion at the expense of judges' sentencing authority, see United States v. Kupa, 976 F. Supp. 2d 417, 419-27 (E.D.N.Y. 2013) (describing the legislative history and Justice Department lobbying related to federal drug statutes, notably 27 U.S.C. § 841 (2012)). 218 See